Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of salidroside to preparation of Parkin protein agonist drug

A technology of salidroside and agonist, which is applied in the field of biomedicine and can solve the problems that the application of salidroside is not disclosed

Inactive Publication Date: 2018-11-06
THE SECOND HOSPITAL AFFILIATED TO WENZHOU MEDICAL COLLEGE
View PDF4 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But other applications of salidroside are not disclosed

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of salidroside to preparation of Parkin protein agonist drug
  • Application of salidroside to preparation of Parkin protein agonist drug
  • Application of salidroside to preparation of Parkin protein agonist drug

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0027] The present invention will be further described below in conjunction with the accompanying drawings and embodiments.

[0028] All surgical interventions, treatments and postoperative animal care procedures in the present invention were strictly implemented in accordance with the regulations of the Animal Ethics Committee of Wenzhou Medical University (wydw2014-0129).

[0029] experimental method

[0030] Nucleus pulposus (NP) cell culture

[0031] Extract NP cells from healthy SD rats (20 males, 100-150g body weight) at 37°C and 5% CO 2 Conditions, cultured in DMEM medium containing 10% fetal bovine serum (FBS; Gibco, Waltham, MA, USA) and 1% penicillin / streptomycin (Invitrogen) for three weeks, except that primary cells were replaced in the first Before the medium was cultured for 6.7±1.4 days, the medium of the remaining cells was changed twice a week. Second generation cells were used in the experiments. Drug treatment: 10nM concentration of TNF-α was added to th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention specifically discloses new application of salidroside, in particularly application of salidroside to the preparation of a Parkin protein agonist drug. By promoting the expression of parkin protein, salidroside, as a Parkin protein agonist, promotes mitochondrial autophagy and mitochondrial homeostasis, inhibiting apoptosis, and thereby the salidroside can be used for treating the neurodegenerative disease and the degenerative disease of the musculoskeletal system.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to the application of salidroside in the preparation of Parkin protein agonist drugs. Background technique [0002] Parkin protein can play multiple functions in organisms through autophagy-lysosome pathway and ubiquitin-proteasome pathway. In the autophagy-lysosome system (ALS), parkin protein can protect cells and inhibit apoptosis by promoting mitophagy, clearing damaged mitochondria, and excessive oxygen free radicals in organisms. In the ubiquitin-proteasome (UPS), parkin protein acts as an E3 ubiquitin ligase, which can bind to substrate proteins and promote their degradation, maintaining intracellular protein homeostasis. Through the UPS pathway, parkin protein can participate in the regulation of multiple processes such as gene transcription and protein degradation in vivo. [0003] Decreased expression or inhibited activity of Parkin protein is the main pathological b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7032A61P25/28A61P19/08A61P21/00
CPCA61K31/7032A61P19/08A61P21/00A61P25/28
Inventor 张小磊章增杰丁远哲王向阳
Owner THE SECOND HOSPITAL AFFILIATED TO WENZHOU MEDICAL COLLEGE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com